Trials / Unknown
UnknownNCT00443105
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Assaf-Harofeh Medical Center · Other Government
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine the efficacy, tolerance and safety of tacrolimus 0.03% ointment in the treatment of intractable allergic conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus 0.03% ointment (Protopic) |
Timeline
- First posted
- 2007-03-05
- Last updated
- 2007-03-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00443105. Inclusion in this directory is not an endorsement.